“Delivery of this report will take 1-3 days after purchase.”
The Big Pharma Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014.
Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.
The initial chapters of this report provide an orientation of 2014′s dealmaking and business activities.
Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, stage of development, technology type and therapeutic indication.
Chapter 2 provides a review of the leading deals during 2014. Deals are listed by headline value, signed by big pharma and big biotech, and most active big pharma. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
Chapter 3 provides a comprehensive listing of the top 50 big pharma companies with a brief summary followed by a comprehensive listing of 2014 deals, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Chapter 4 provides a comprehensive directory of all partnering deals announced during 2014.
The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), therapy area and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
The report series also includes numerous tables and figures that illustrate the trends and activities in big pharma partnering and dealmaking during 2014.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products during 2014.
“Delivery of this report will take 1-3 days after purchase.”Purchase a copy of the report at http://bit.ly/1MWTgZo
Big Pharma Deals and Alliances of 2014 provides the reader with the following key benefits:
In-depth understanding of recent big pharma dealmaking trends during 2014
Comprehensive access to all big pharma deals entered into by the world’s biopharma companies during 2014
Understand the key deal terms companies have agreed in previous deals
Full listing of big pharma deals by company A-Z, deal type, technology and therapy focus
Identify leading big pharma deals by value during 2014
Identify the most active big pharma industry dealmakers during 2014
Undertake due diligence to assess suitability of your proposed deal terms for partner companies
Big Pharma Deals and Alliances of 2014 is intended to provide the reader with an in-depth understanding and access to partnering and M&A trends and structure of deals entered into by leading companies worldwide.
Big Pharma Deals and Alliances of 2014 includes:
Trends in dealmaking in the biopharma industry during 2014
Analysis of partnering and M&A deal structure
Comprehensive directory of partnering and M&A deals in 2014
Links to online access to all deals and alliances
The leading partnering and M&A deals by value in 2014
Most active partnering and M&A dealmakers during 2014
In Big Pharma Deals and Alliances of 2014 the partnering and M&A deals are listed by:
Stage of development at signing
Deal component type
Each deal title links via Weblink to an online version of the deal record at Current Agreements and where available, the contract document, providing easy access to each contract document on demand.
“Delivery of this report will take 1-3 days after purchase.”For more Information on the report, inquire at http://bit.ly/1LCYoqa